Author

Yiyuan Shen

Observed names: Shen Y, Yinming Shen

Institution: Beijing Institute for Stem Cell and Regenerative Medicine

Observed institutions: University of Electronic Science and Technology of China, Chinese Academy of Sciences, Guangzhou Institutes of Biomedicine and Health, Sichuan Cancer Hospital, University of Chinese Academy of Sciences, Institute of Zoology, Beijing Institute for Stem Cell and Regenerative Medicine

ORCID: 0009-0000-9894-0268

Observed ORCID: 0009-0000-9894-0268

OpenAlex ID: A5110995116

Engineered CRO-CD7 CAR-NK cells derived from pluripotent stem cells avoid fratricide and efficiently suppress human T-cell malignancies

2025 · Yunqing Lin, Ziyun Xiao, et al. · Journal of Hematology & Oncology · 17

Hypoimmunogenic CD19 CAR-NK cells derived from embryonic stem cells suppress the progression of human B-cell malignancies in xenograft animals

2024 · Qi Zhang, Chengxiang Xia, et al. · Frontiers in Immunology · 9

CD33 KO -CD33-mesothelin Loop CAR design avoids fratricide and improves efficacy of iNK cells against acute myeloid leukemia

2025 · Yao Wang, Xiujuan Zheng, et al. · Journal for ImmunoTherapy of Cancer · 8

Pluripotent stem cell-derived CAR-NK progenitor therapy targets minimal residual disease and prevents relapse in leukemia models

2026 · Zhiqian Wang, Leqiang Zhang, et al. · Cell stem cell · 7

Prognosis Evaluation of the Progression of Diffuse Large B-Cell Lymphoma within 24 Months

2022 · Hong H, Lin T, et al. · Annals of Hematology & Oncology · 1

Pluripotent stem cell-derived siTNK cells attack tumors via a synthetic CD8-CD28-TCR complex

2025 · Xiujuan Zheng, Fan Zhang, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Traffic Prediction Approach based on Deep Learning for Heterogeneous Communication Networks

2024 · Yinming Shen, Licheng Zhang, et al. · IEEE Smart World Congress (SWC)

Works count: 7

Citation count: 42

H-index: 4

I10-index: 1